United States · Markets & Finance · MarketWatch

Biopharmaceutical Company Bambusa Therapeutics Files for IPO

Published by MarketWatch · United States 13 h ago

Biopharmaceutical company Bambusa Therapeutics filed for an initial public offering, and said it applied to list on the Nasdaq Global Select Market under the symbol BBTX. The…

Read the full article on MarketWatch Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)

Also worth reading

TechCrunch

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

Business Insider

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

Seeking Alpha

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

CNBC

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

NYT Business

Big Controversy Upends a Contest About Microscopic Videos

OilPrice.com